AzurRx BioPharma Announces Positive Results from Independent Data Monitoring Committee Review of Safety Data from Part 1 of RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections

NEXT STORY
CRISPR Based Therapeutics Market, 2030
PREV STORY
1Life Healthcare (One Medical) Executives to Participate in Upcoming Investor Conferences
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Merus Announces Third Quarter 2017 Financial Results and Clinical Highlights

UTRECHT, The Netherlands, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology ...

author_avatar
NASDAQ Market News

Loxo Oncology Announces Accepted Abstracts at the 88th Annual Meeting of the American Thyroid Association

STAMFORD, Conn., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical ...

author_avatar
NASDAQ Market News

AngioDynamics Announces Secondary Offering of 2,250,000 Shares of Common Stock by Selling Stockholders

ALBANY, N.Y., Aug. 01, 2016 (GLOBE NEWSWIRE) -- AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider ...

author_avatar
NASDAQ Market News